abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Disclosure

21 Mar 2022

Author:
Novo Nordisk

Novo Nordisk response

...We have provided emergency funds to all affected employees to help meet the costs of evacuation. Furthermore, we are coordinating support in neighbouring countries for colleagues and/or their families who wish to leave Ukraine...

We are doing all we can to maintain the supply of essential medicines to patients living with chronic diseases in Ukraine.

We have donated up to two months' supply of life-saving medicine for diabetes and haemophilia from our current stock in Ukraine to the Ministry of Health...

We have established a hotline for patients and healthcare providers in Ukraine to inform about the availability of our products. We will do our utmost to provide all necessary information...

We continue to follow our processes including thorough compliance assessments, including but not limited to close follow-up to secure compliance with sanctions and export control. We have implemented very thorough sanction screening set-up for both individuals, vendors, third parties, and banks. Further, we continue to follow our enhanced processes regarding thorough compliance assessments and due diligences, including human rights.

We have a strong set-up in place with cross-functional Crisis Response Teams, constantly assessing the situation and required measures, based on external and internal sources.

Timeline